Satoshi Kakugawa

1. Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy
   2020/05/12 by Atsushi Suzuki, Satoshi Kakugawa, Masafumi Miyoshi +4 · 1 citation
   Medicine · #Multiple Myeloma Research and Treatments #Cell Adhesion Molecules Research #Monoclonal and Polyclonal Antibodies Research